Guardant Health
GH
#1080
Rank
ยฃ16.35 B
Marketcap
ยฃ121.85
Share price
-3.76%
Change (1 day)
163.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.61

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.64. In 2025 the company made an earnings per share (EPS) of -ยฃ2.50 an increase over its 2024 EPS that were of -ยฃ2.69.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.614.46%
2025-ยฃ2.50-7.02%
2024-ยฃ2.69-16.82%
2023-ยฃ3.24-33.13%
2022-ยฃ4.8460%
2021-ยฃ3.0255.04%
2020-ยฃ1.95207.14%
2019-ยฃ0.64-19.81%
2018-ยฃ0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ0.02720-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.85-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA